TACE in HCC Patients Aged Greater Versus Less Than 80 Years

หัตถการ TACE - โรงพยาบาลธรรมศาสตร์เฉลิมพระเกียรติ tace EMERALD-1 is a randomised, double-blind, placebo-controlled, multicentre, global Phase III trial of Imfinzi plus TACE concurrently, followed by tace 441Background: Acute elevations of serum transaminases and bilirubin after TACE are commonly observed in pts with HCC However, real-world incidence of

tace TACE uses small beads containing chemotherapy that are directly injected into the blood vessel supplying the tumour; this has the advantage that the